These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 19009980)

  • 21. Activation of complement by circulating immune complexes isolated from leprosy patients.
    Tyagi P; Ramanathan VD; Girdhar BK; Katoch K; Bhatia AS; Sengupta U
    Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):31-8. PubMed ID: 2319186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA Sensing via TLR-9 Constitutes a Major Innate Immunity Pathway Activated during Erythema Nodosum Leprosum.
    Dias AA; Silva CO; Santos JP; Batista-Silva LR; Acosta CC; Fontes AN; Pinheiro RO; Lara FA; Machado AM; Nery JA; Sarno EN; Pereira GM; Pessolani MC
    J Immunol; 2016 Sep; 197(5):1905-13. PubMed ID: 27474073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxoplasma gondii infection and high levels of IgE are associated to erythema nodosum leprosy (ENL).
    Nascimento LS; de Castro YS; Figueira JA; Souza RDC; da Silva JA; Nahn EP; Peixoto-Rangel AL
    PLoS One; 2024; 19(6):e0300704. PubMed ID: 38865430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An in vitro model for the lepromatous leprosy granuloma: fate of Mycobacterium leprae from target macrophages after interaction with normal and activated effector macrophages.
    Hagge DA; Ray NA; Krahenbuhl JL; Adams LB
    J Immunol; 2004 Jun; 172(12):7771-9. PubMed ID: 15187161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The efficacy of a cell-mediated reaction in the disposal of M. leprae in human skin.
    Kaplan G
    Immunol Lett; 1988 Nov; 19(3):223-7. PubMed ID: 3069709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro tumor necrosis factor production by mononuclear cells from lepromatous leprosy patients and from patients with erythema nodosum leprosum.
    Santos DO; Suffys PN; Bonifácio K; Marques MA; Sarno EN
    Clin Immunol Immunopathol; 1993 Jun; 67(3 Pt 1):199-203. PubMed ID: 8500267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T cell-monocyte contact enhances tumor necrosis factor-alpha production in response to Mycobacterium leprae.
    Sampaio EP; Oliveira RB; Warwick-Davies J; Neto RB; Griffin GE; Shattock RJ
    J Infect Dis; 2000 Nov; 182(5):1463-72. PubMed ID: 11023469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo effect of delipidified cell component of Mycobacterium leprae in relation to infection with leprosy bacteria in mice.
    Damle A; Mahadevan PR
    Indian J Lepr; 1993; 65(3):271-82. PubMed ID: 8283062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thalidomide does not modify the ability of cells in leprosy patients to incorporate [3H]-thymidine when incubated with M. leprae antigens.
    Tadesse A; Taye E; Sandoval F; Shannon EJ
    Lepr Rev; 2003 Sep; 74(3):206-14. PubMed ID: 14577465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of purification and fluorescent staining on viability of Mycobacterium leprae.
    Lahiri R; Randhawa B; Krahenbuhl JL
    Int J Lepr Other Mycobact Dis; 2005 Sep; 73(3):194-202. PubMed ID: 16830641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erythema nodosum leprosum is associated with up-regulation of polyclonal IgG1 antibody synthesis.
    Kifayet A; Shahid F; Lucas S; Hussain R
    Clin Exp Immunol; 1996 Dec; 106(3):447-53. PubMed ID: 8973611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An attempt to induce a histological ENL symptom in M. leprae infected nude mice.
    Subowo
    Nihon Rai Gakkai Zasshi; 1986; 55(4):173-85. PubMed ID: 3323158
    [No Abstract]   [Full Text] [Related]  

  • 33. Delayed-type hypersensitivity reactions followed by erythema nodosum leprosum.
    Rea TH; Sieling PA
    Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):316-27. PubMed ID: 9934358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of TNF-Producing CD8
    Silva PHL; Santos LN; Mendes MA; Nery JAC; Sarno EN; Esquenazi D
    Am J Trop Med Hyg; 2019 Feb; 100(2):377-385. PubMed ID: 30652669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defect in the generation of cytotoxic T cells in lepromatous leprosy.
    Stach JL; Strobel M; Fumoux F; Bach JF
    Clin Exp Immunol; 1982 Jun; 48(3):633-40. PubMed ID: 6214342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The immunopathology of erythema nodosum leprosum: the role of extravascular complexes.
    Ridley MJ; Ridley DS
    Lepr Rev; 1983 Jun; 54(2):95-107. PubMed ID: 6350778
    [No Abstract]   [Full Text] [Related]  

  • 37. Immune complexes and complement hypercatabolism in patients with leprosy.
    Bjorvatn B; Barnetson RS; Kronvall G; Zubler RH; Lambert PH
    Clin Exp Immunol; 1976 Dec; 26(3):388-96. PubMed ID: 1009681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C-reactive protein and apoB containing lipoproteins are associated with Mycobacterium leprae in lesions of human leprosy.
    Ridley MJ; Ridley DS; De Beer FC; Pepys MB
    Clin Exp Immunol; 1984 Jun; 56(3):545-52. PubMed ID: 6378453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistological studies of skin biopsies from patients with lepromatous leprosy.
    Mshana RN; Humber DP; Belehu A; Harboe M
    J Clin Immunol; 1983 Jan; 3(1):22-9. PubMed ID: 6338025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunologic identification of M. leprae. Immunofluorescence and complement fixation.
    Matsuo E; Skinsnes OK
    Int J Lepr Other Mycobact Dis; 1976; 44(3):301-14. PubMed ID: 61949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.